Report date: Apr 30, 2024
Conflict count: 350192
Publisher: Wiley (Blackwell Publishing)
Title count: 478
Conflict count: 16765


==========================================================

Created: 2009-04-03 08:42:08.0
ConfID: 4798572
CauseID: 767228023
OtherID: 769166818
JT: Epilepsia
MD: null, 50 ,4,971,2009,ERRATA
DOI: 10.1111/j.1528-1167.2009.02138_2.x(Journal) (4798572-N )
DOI: 10.1111/j.1528-1167.2009.02138_1.x(Journal)
==========================================================

Created: 2019-04-04 18:50:39.0
ConfID: 5463275
CauseID: 1442555451
OtherID: 14417299
JT: Epilepsia
MD: French, 43 ,s10,1,2002,Foreward
DOI: 10.1046/j.1528-1157.43.s10.1.x(Journal) (5463275-N )
DOI: 10.1046/j.1528-1157.43.s10.3.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463276
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Ptacek, 42 ,s5,35,2001,Channelopathies: Episodic Disorders of the Nervous System
DOI: 10.1046/j.1528-1157.2001.0420s5035.x(Journal) (5463276-N )
DOI: 10.1111/j.1528-1167.2001.0s007.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463277
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Spear, 42 ,s5,31,2001,Pharmacogenetics and Antiepileptic Drugs
DOI: 10.1046/j.1528-1157.2001.0420s5031.x(Journal) (5463277-N )
DOI: 10.1111/j.1528-1167.2001.0s006.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463278
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Cooper, 42 ,s5,49,2001,Potassium Channels: How Genetic Studies of Epileptic Syndromes Open Paths to New Therapeutic Targets and Drugs
DOI: 10.1046/j.1528-1157.2001.0420s5049.x(Journal) (5463278-N )
DOI: 10.1111/j.1528-1167.2001.0s009.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463279
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Roden, 42 ,s5,44,2001,Principles in Pharmacogenetics
DOI: 10.1046/j.1528-1157.2001.0420s5044.x(Journal) (5463279-N )
DOI: 10.1111/j.1528-1167.2001.0s008.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463280
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Berkovic, 42 ,s5,16,2001,Genetics of the Epilepsies
DOI: 10.1046/j.1528-1157.2001.0420s5016.x(Journal) (5463280-N )
DOI: 10.1111/j.1528-1167.2001.0s003.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463281
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Noebels, 42 ,s5,11,2001,Modeling Human Epilepsies in Mice
DOI: 10.1046/j.1528-1157.2001.0420s5011.x(Journal) (5463281-N )
DOI: 10.1111/j.1528-1167.2001.0s002.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463282
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Ottman, 42 ,s5,24,2001,Progress in the Genetics of the Partial Epilepsies
DOI: 10.1046/j.1528-1157.2001.0420s5024.x(Journal) (5463282-N )
DOI: 10.1111/j.1528-1167.2001.0s005.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463283
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Groden, 42 ,s5,2,2001,Overview of Genetics for the Clinician
DOI: 10.1046/j.1528-1157.2001.0420s5002.x(Journal) (5463283-N )
DOI: 10.1111/j.1528-1167.2001.0s001.x(Journal)
==========================================================

Created: 2019-04-04 18:52:53.0
ConfID: 5463284
CauseID: 1442555491
OtherID: 139756937
JT: Epilepsia
MD: Privitera, 42 ,s5,1,2001,Introduction
DOI: 10.1046/j.1528-1157.2001.0420s5001.x(Journal) (5463284-N )
DOI: 10.1111/j.1528-1167.2001.042s5.x(Journal)
==========================================================

Created: 2019-04-04 18:54:10.0
ConfID: 5463287
CauseID: 1442555524
OtherID: 139357174
JT: Epilepsia
MD: Mikati, 45 ,3,296,2004,Neuronal Cell Death in a Rat Model of Mesial Temporal Lobe Epilepsy Is Induced by the Initial Status Epilepticus and Not by Later Repeated Spontaneous Seizures
DOI: 10.1111/j.0013-9580.2004.t01-1-58503.x(Journal) (5463287-N )
DOI: 10.1111/j.0013-9580.2004.58503.x(Journal)
==========================================================

Created: 2023-09-25 14:28:57.0
ConfID: 6935440
CauseID: 1590640587
JT: Epilepsia
MD: null, 35 ,s1,null,1994,Panel Discussion
DOI: 10.1111/j.1528-1157.1994.tb05930.x(Journal) (6935440-N )
DOI: 10.1111/j.1528-1157.1994.tb05927.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935459
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Leppik, 42 ,s4,44,2001,The Place of Levetiracetam in the Treatment of Epilepsy
DOI: 10.1046/j.1528-1157.2001.0420s4044.x(Journal) (6935459-N )
DOI: 10.1111/j.1528-1167.2001.00010.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935460
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Leppik, 42 ,s4,1,2001,Issues in the Treatment of Epilepsy
DOI: 10.1046/j.1528-1157.2001.0420s4001.x(Journal) (6935460-N )
DOI: 10.1111/j.1528-1167.2001.00001.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935461
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Kupferberg, 42 ,s4,7,2001,Animal Models Used in the Screening of Antiepileptic Drugs
DOI: 10.1046/j.1528-1157.2001.0420s4007.x(Journal) (6935461-N )
DOI: 10.1111/j.1528-1167.2001.00002.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935462
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Klitgaard, 42 ,s4,13,2001,Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?
DOI: 10.1046/j.1528-1157.2001.0420s4013.x(Journal) (6935462-N )
DOI: 10.1111/j.1528-1167.2001.00003.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935463
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Faught, 42 ,s4,19,2001,Pharmacokinetic Considerations in Prescribing Antiepileptic Drugs
DOI: 10.1046/j.1528-1157.2001.0420s4019.x(Journal) (6935463-N )
DOI: 10.1111/j.1528-1167.2001.00004.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935464
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Radtke, 42 ,s4,24,2001,Pharmacokinetics of Levetiracetam
DOI: 10.1046/j.1528-1157.2001.0420s4024.x(Journal) (6935464-N )
DOI: 10.1111/j.1528-1167.2001.00005.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935465
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Ferrendelli, 42 ,s4,28,2001,Concerns with Antiepileptic Drug Initiation: Safety, Tolerability, and Efficacy
DOI: 10.1046/j.1528-1157.2001.0420s4028.x(Journal) (6935465-N )
DOI: 10.1111/j.1528-1167.2001.00006.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935466
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Privitera, 42 ,s4,31,2001,Efficacy of Levetiracetam: A Review of Three Pivotal Clinical Trials
DOI: 10.1046/j.1528-1157.2001.0420s4031.x(Journal) (6935466-N )
DOI: 10.1111/j.1528-1167.2001.00007.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935467
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: Harden, 42 ,s4,36,2001,Safety Profile of Levetiracetam
DOI: 10.1046/j.1528-1157.2001.0420s4036.x(Journal) (6935467-N )
DOI: 10.1111/j.1528-1167.2001.00008.x(Journal)
==========================================================

Created: 2023-09-25 14:31:21.0
ConfID: 6935468
CauseID: 1590641296
OtherID: 139756933
JT: Epilepsia
MD: French, 42 ,s4,40,2001,Use of Levetiracetam in Special Populations
DOI: 10.1046/j.1528-1157.2001.0420s4040.x(Journal) (6935468-N )
DOI: 10.1111/j.1528-1167.2001.00009.x(Journal)
==========================================================

Created: 2023-09-25 14:35:54.0
ConfID: 6935483
CauseID: 1590642669
JT: Epilepsia
MD: null, 44 ,s9,4,2003,December 8, 2003
DOI: 10.1046/j.1528-1157.44.s9.3.x(Journal) (6935483-N )
DOI: 10.1046/j.1528-1157.44.s9.4.x(Journal)
==========================================================

Created: 2023-09-25 14:36:41.0
ConfID: 6935966
CauseID: 1590642917
JT: Epilepsia
MD: null, 28 ,s1,null,1987,Discussion
DOI: 10.1111/j.1528-1157.1987.tb05762.x(Journal) (6935966-N )
DOI: 10.1111/j.1528-1157.1987.tb05758.x(Journal)
==========================================================

Created: 2023-09-25 14:47:38.0
ConfID: 6936711
CauseID: 1590646231
OtherID: 14417365
JT: Epilepsia
MD: Mayanagi, 43 ,s9,1,2002,Preface
DOI: 10.1046/j.1528-1157.43.s9.1.x(Journal) (6936711-N )
DOI: 10.1046/j.1528-1157.43.s9.5.x(Journal)
==========================================================

Created: 2023-09-26 08:54:49.0
ConfID: 6937243
CauseID: 1590765247
OtherID: 201422585
JT: Epilepsia
MD: Jibiki, 41 ,s9,59,2000,Regional Relationships Between Focal Abnormalities on SPECTs and High Power Zones on EEG Topographies of Background H Activities in Adult Patients with Partial Epilepsies
DOI: 10.1111/j.1528-1157.2000.tb02245.x(Journal) (6937243-N )
DOI: 10.1111/j.1528-1157.2000.tb02244.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937329
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Wada, 42 ,s6,2,2001,Predisposed Susceptibility and Partial Seizure Disorder
DOI: 10.1046/j.1528-1157.2001.0420s6002.x(Journal) (6937329-N )
DOI: 10.1046/j.1528-1157.42.s6.11.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937330
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Engel, 42 ,s6,3,2001,Intractable Epilepsy: Definition and Neurobiology
DOI: 10.1046/j.1528-1157.2001.0420s6003.x(Journal) (6937330-N )
DOI: 10.1046/j.1528-1157.42.s6.10.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937331
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Wachi, 42 ,s6,4,2001,Neuropsychological Changes After Surgical Treatment for Temporal Lobe Epilepsy
DOI: 10.1046/j.1528-1157.2001.0420s6004.x(Journal) (6937331-N )
DOI: 10.1046/j.1528-1157.42.s6.1.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937332
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Inoue, 42 ,s6,13,2001,Psychiatric Disorders Before and After Surgery for Epilepsy
DOI: 10.1046/j.1528-1157.2001.0420s6013.x(Journal) (6937332-N )
DOI: 10.1046/j.1528-1157.42.s6.3.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937333
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Mayanagi, 42 ,s6,19,2001,Psychiatric and Neuropsychological Problems in Epilepsy Surgery: Analysis of 100 Cases That Underwent Surgery
DOI: 10.1046/j.1528-1157.2001.05405.x(Journal) (6937333-N )
DOI: 10.1046/j.1528-1157.2001.0420s6019.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937334
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Matsuda, 42 ,s6,29,2001,Neuroradiologic Findings in Focal Cortical Dysplasia: Histologic Correlation with Surgically Resected Specimens
DOI: 10.1046/j.1528-1157.2001.0420s6029.x(Journal) (6937334-N )
DOI: 10.1046/j.1528-1157.42.s6.6.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937335
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Kameyama, 42 ,s6,37,2001,Surgical Strategy and Outcomes for Epileptic Patients with Focal Cortical Dysplasia or Dysembryoplastic Neuroepithelial Tumor
DOI: 10.1046/j.1528-1157.2001.0420s6037.x(Journal) (6937335-N )
DOI: 10.1046/j.1528-1157.42.s6.7.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937336
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Matsuoka, 42 ,s6,42,2001,Neuropsychology of Epilepsy
DOI: 10.1046/j.1528-1157.2001.0420s6042.x(Journal) (6937336-N )
DOI: 10.1046/j.1528-1157.42.s6.8.x(Journal)
==========================================================

Created: 2023-09-26 09:05:29.0
ConfID: 6937337
CauseID: 1590768401
OtherID: 14417126
JT: Epilepsia
MD: Sato, 42 ,s6,1,2001,Preface
DOI: 10.1046/j.1528-1157.2001.0420s6001.x(Journal) (6937337-N )
DOI: 10.1046/j.1528-1157.42.s6.12.x(Journal)
==========================================================

Created: 2023-09-26 09:05:33.0
ConfID: 6937338
CauseID: 1590768444
OtherID: 14417143
JT: Epilepsia
MD: Faught, 42 ,s8,4,2001,The Challenge of Treatment Selection for Epilepsy
DOI: 10.1046/j.1528-1157.2001.0420s8004.x(Journal) (6937338-N )
DOI: 10.1046/j.1528-1157.42.s8.4.x(Journal)
==========================================================

Created: 2023-09-26 09:05:33.0
ConfID: 6937339
CauseID: 1590768444
OtherID: 14417143
JT: Epilepsia
MD: Willmore, 42 ,s8,6,2001,Treatment of Benign Epilepsy Syndromes Throughout Life
DOI: 10.1046/j.1528-1157.2001.0420s8006.x(Journal) (6937339-N )
DOI: 10.1046/j.1528-1157.42.s8.5.x(Journal)
==========================================================

Created: 2023-09-26 09:05:33.0
ConfID: 6937340
CauseID: 1590768444
OtherID: 14417143
JT: Epilepsia
MD: Nordli, 42 ,s8,10,2001,Special Needs of the Adolescent with Epilepsy
DOI: 10.1046/j.1528-1157.2001.0420s8010.x(Journal) (6937340-N )
DOI: 10.1046/j.1528-1157.42.s8.6.x(Journal)
==========================================================

Created: 2023-09-26 09:05:33.0
ConfID: 6937341
CauseID: 1590768444
OtherID: 14417143
JT: Epilepsia
MD: Boggs, 42 ,s8,18,2001,Elderly Patients with Systemic Disease
DOI: 10.1046/j.1528-1157.2001.0420s8018.x(Journal) (6937341-N )
DOI: 10.1046/j.1528-1157.42.s8.7.x(Journal)
==========================================================

Created: 2023-09-26 09:05:33.0
ConfID: 6937342
CauseID: 1590768444
OtherID: 14417143
JT: Epilepsia
MD: Loring, 42 ,s8,24,2001,Cognitive and Behavioral Effects of Epilepsy Treatment
DOI: 10.1046/j.1528-1157.2001.0420s8024.x(Journal) (6937342-N )
DOI: 10.1046/j.1528-1157.42.s8.8.x(Journal)
==========================================================

Created: 2023-09-26 09:07:16.0
ConfID: 6937366
CauseID: 1590768940
JT: Epilepsia
MD: null, 40 ,s1,null,1999,Panel Discussion
DOI: 10.1111/j.1528-1157.1999.tb00881.x(Journal) (6937366-N )
DOI: 10.1111/j.1528-1157.1999.tb00877.x(Journal)
==========================================================

Created: 2023-10-10 19:53:52.0
ConfID: 6959802
CauseID: 1592509514
OtherID: 267759700
JT: Epilepsia
MD: Ngoungou, 47 ,5,873,2006,Epilepsy as a Consequence of Cerebral Malaria in Area in Which Malaria Is Endemic in Mali, West Africa
DOI: 10.1111/j.1528-1167.2006.00524.x(Journal) (6959802-N )
DOI: 10.1111/j.0013-9580.2006.00558.x(Journal)
==========================================================

Created: 2023-10-10 19:58:25.0
ConfID: 6959816
CauseID: 1592510653
OtherID: 165167019
JT: Epilepsia
MD: Grabenbauer, 46 ,3,457,2005,Gamma Knife Surgery in Mesial Temporal Lobe Epilepsy
DOI: 10.1111/j.0013-9580.2005.t01-1-53904.x(Journal) (6959816-N )
DOI: 10.1111/j.0013-9580.2005.53904.x(Journal)
==========================================================

Created: 2023-10-10 20:00:34.0
ConfID: 6959826
CauseID: 1592511228
OtherID: 213586904
JT: Epilepsia
MD: null, 46 ,10,1557,2005,Basic Science
DOI: 10.1111/j.1528-1167.2005.00105.x(Journal) (6959826-N )
DOI: 10.1111/j.1528-1167.2005.00105_1.x(Journal)
==========================================================

Created: 2023-10-13 18:30:33.0
ConfID: 6961408
CauseID: 1592898178
OtherID: 139357256
JT: Epilepsia
MD: Derakhshan, 45 ,6,715,2004,Late Language Transfer vs. Immutability of Command Center
DOI: 10.1111/j.0013-9580.2004.t01-1-70103.x(Journal) (6961408-N )
DOI: 10.1111/j.0013-9580.2004.70103.x(Journal)
==========================================================

Created: 2023-10-16 18:44:53.0
ConfID: 6964153
CauseID: 1593265334
OtherID: 139355222
JT: Epilepsia
MD: Osorio, 42 ,2,288,2001,Refractory Idiopathic Status Epilepticus
DOI: 10.1046/j.1528-1157.2001.29300-2.x(Journal) (6964153-N )
DOI: 10.1111/j.1528-1167.2001.29300-2.x(Journal)
==========================================================

Created: 2023-10-16 18:44:53.0
ConfID: 6964154
CauseID: 1593265334
OtherID: 139355222
JT: Epilepsia
MD: Danielsen, 42 ,2,288,2001,Lactate and Other Metabolic Changes in Neuronal Migration Disorders
DOI: 10.1046/j.1528-1157.2001.29300-3.x(Journal) (6964154-N )
DOI: 10.1111/j.1528-1167.2001.29300-3.x(Journal)
==========================================================

Created: 2023-10-16 18:44:53.0
ConfID: 6964155
CauseID: 1593265334
OtherID: 139355222
JT: Epilepsia
MD: Simone, 42 ,2,288,2001,Reply
DOI: 10.1046/j.1528-1157.2001.29300-4.x(Journal) (6964155-N )
DOI: 10.1111/j.1528-1167.2001.29300-4.x(Journal)
==========================================================

Created: 2023-10-16 18:44:53.0
ConfID: 6964156
CauseID: 1593265334
OtherID: 139355222
JT: Epilepsia
MD: Lhatoo, 42 ,2,288,2001,Reply
DOI: 10.1046/j.1528-1157.2001.29300-6.x(Journal) (6964156-N )
DOI: 10.1111/j.1528-1167.2001.29300-6.x(Journal)
==========================================================

Created: 2023-10-16 18:44:53.0
ConfID: 6964157
CauseID: 1593265334
OtherID: 139355222
JT: Epilepsia
MD: DeToledo, 42 ,2,288,2001,Cardiac Arrest After Fast Intravenous Infusion of Phenytoin Mistaken for Fosphenytoin
DOI: 10.1046/j.1528-1157.2001.29300.x(Journal) (6964157-N )
DOI: 10.1111/j.1528-1167.2001.29300.x(Journal)